ϳԹ

Skip to main content
red-blood-cells-feat

Enterprise licensed by Technology Transfer Office raises $9.1 million in funding

MEDIA | July 18, 2018
STORY BY: EDITORIAL STAFF
Crain’s Cleveland Business: The ϳԹ Technology Transfer Office granted an exclusive license to XaTek Inc. in 2016 for a blood clotting device. The enterprise has now raised $9.1 million to fund further research and trials.